Chemomab Therapeutics Ltd. General And Administrative Expense
Chemomab Therapeutics Ltd. (CMMB) reported General And Administrative Expense of $5.49 million for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:GeneralAndAdministrativeExpense · last filed 2019-04-24
| Period end | General And Administrative Expense 12 month |
|---|---|
| 2018-12-31 | $5.49M 20-F · filed 2019-04-24 |
| 2017-12-31 | $3.16M 20-F · filed 2019-04-24 |
| 2016-12-31 | $2.26M 20-F · filed 2019-04-24 |